The latest closing stock price for Kiniksa Pharmaceuticals as of January 21, 2025 is 18.71.
An investor who bought $1,000 worth of Kiniksa Pharmaceuticals stock at the IPO in 2018 would have $-39 today, roughly 0 times their original investment - a -0.57% compound annual growth rate over 7 years.
The all-time high Kiniksa Pharmaceuticals stock closing price was 30.93 on September 20, 2018.
The Kiniksa Pharmaceuticals 52-week high stock price is 28.15, which is 50.5% above the current share price.
The Kiniksa Pharmaceuticals 52-week low stock price is 16.56, which is 11.5% below the current share price.
The average Kiniksa Pharmaceuticals stock price for the last 52 weeks is 21.44.
An investor who bought $1,000 worth of Kiniksa Pharmaceuticals stock at the IPO in 2018 would have $-39 today, roughly 0 times their original investment - a -0.57% compound annual growth rate over 7 years.
The all-time high Kiniksa Pharmaceuticals stock closing price was 30.93 on September 20, 2018.
The Kiniksa Pharmaceuticals 52-week high stock price is 28.15, which is 50.5% above the current share price.
The Kiniksa Pharmaceuticals 52-week low stock price is 16.56, which is 11.5% below the current share price.
The average Kiniksa Pharmaceuticals stock price for the last 52 weeks is 21.44.